| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/11/2023 | 978.43% | HC Wainwright & Co. | → $11 | Reiterates | Buy → Buy |
| 06/14/2023 | 978.43% | HC Wainwright & Co. | → $11 | Reiterates | → Buy |
| 06/06/2023 | 978.43% | HC Wainwright & Co. | → $11 | Reiterates | Buy → Buy |
| 05/25/2023 | 978.43% | HC Wainwright & Co. | → $11 | Reiterates | → Buy |
| 05/16/2023 | 978.43% | HC Wainwright & Co. | → $11 | Reiterates | Buy → Buy |
| 04/21/2023 | 978.43% | HC Wainwright & Co. | → $11 | Upgrades | Neutral → Buy |
| 03/01/2022 | 586.27% | Ladenburg Thalmann | → $7 | Initiates Coverage On | → Buy |
| 05/18/2021 | 292.16% | Guggenheim | → $4 | Initiates Coverage On | → Buy |
| 12/22/2020 | — | Noble Capital Markets | Upgrades | Market Perform → Outperform | |
| 08/24/2020 | — | HC Wainwright & Co. | Downgrades | Buy → Neutral | |
| 07/25/2019 | 1076.47% | Noble Capital Markets | → $12 | Initiates Coverage On | → Outperform |
What is the target price for Onconova Therapeutics (ONTX)?
The latest price target for Onconova Therapeutics (NASDAQ: ONTX) was reported by HC Wainwright & Co. on August 11, 2023. The analyst firm set a price target for $11.00 expecting ONTX to rise to within 12 months (a possible 978.43% upside). 6 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Onconova Therapeutics (ONTX)?
The latest analyst rating for Onconova Therapeutics (NASDAQ: ONTX) was provided by HC Wainwright & Co., and Onconova Therapeutics reiterated their buy rating.
When is the next analyst rating going to be posted or updated for Onconova Therapeutics (ONTX)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Onconova Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Onconova Therapeutics was filed on August 11, 2023 so you should expect the next rating to be made available sometime around August 11, 2024.
Is the Analyst Rating Onconova Therapeutics (ONTX) correct?
While ratings are subjective and will change, the latest Onconova Therapeutics (ONTX) rating was a reiterated with a price target of $0.00 to $11.00. The current price Onconova Therapeutics (ONTX) is trading at is $1.02, which is within the analyst's predicted range.